Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAK inhibitor
Pharma
FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo
Leo has scored an FDA nod that makes its JAK inhibitor Anzupgo the first therapeutic in the U.S. specifically indicated for chronic hand eczema.
Kevin Dunleavy
Jul 24, 2025 8:45am
Sun launches alopecia med Leqselvi after Incyte settlement
Jul 14, 2025 11:21am
Incyte posts mixed Opzelura results in prurigo nodularis
Mar 10, 2025 11:23am
Incyte's JAK cream Opzelura slows while Leo competition looms
May 3, 2024 10:53am
Incyte's Opzelura scores in hidradenitis suppurativa study
Mar 11, 2024 1:58pm
With FDA nod for Crohn's, AbbVie wins 7th indication for Rinvoq
May 18, 2023 4:25pm
